For pharmaceutical and biotechnology companies, supply chain risk management is critical as disruptions can impact patient health and damage reputations. Specialty suppliers, small volumes, and complex shipping requirements increase vulnerabilities, while regulatory demands and limited visibility compound challenges. Over-reliance on regional supplier clusters in geopolitically sensitive areas heightens risks. Sphera advocates for digitalizing supply chain risk management to enhance transparency, improve resilience, and ensure compliance, helping pharma and biotech firms safeguard product quality and continuity in this high-stakes industry.

Join for free to read